Find clinical trials for Sanofi. Search for Sanofi clinical trials in different cities and states across the United States.
Filter
Filter results
Results: 67
A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors
for
Solid Tumor
Location: Providence RI, New York NY, Hackensack NJ, Newark DE,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT05584670
Phase1, Phase2, Recruiting
A Real-world Long-term Safety and Immunogenicity Study of Olipudase Alfa Therapy in Pediatric Patients Less Than 2 Years of Age With Acid Sphingomyelinase Deficiency (ASMD)
Location: Philadelphia PA, Columbus OH, Cincinnati OH, Chicago IL,
Sponsor: Sanofi
Sex: All
Age: 0 - 2
Code: NCT06192576
Recruiting
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
for
Atopic Dermatitis
Location: Portsmouth NH, Warwick RI, Falls Church VA,
Sponsor: Sanofi
Sex: All
Age: 12+
Code: NCT07290803
Recruiting
A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
for
Immunoglobulin G4 Related Disease
Location: Boston MA, Sherbrooke, Miami FL, Margate FL,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT07190196
Phase3, Recruiting
A Study to Investigate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants Aged 10 to 55 Years of Age With Non-congenital Myotonic Dystrophy Type 1
for
Myotonic Dystrophy
Location: New York NY, Montreal, Richmond VA, Tampa FL,
Sponsor: Sanofi
Sex: All
Age: 10 - 55
Code: NCT06844214
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
for
Type 1 Diabetes Mellitus
Location: Halifax, New Haven CT, New York NY, Philadelphia PA,
Sponsor: Sanofi
Sex: All
Age: 1 - 25
Code: NCT07088068
Phase3, Recruiting
Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP)